These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10474152)

  • 41. Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
    Facente SN; Reiersen AM; Lenze EJ; Boulware DR; Klausner JD
    Drugs; 2021 Dec; 81(18):2081-2089. PubMed ID: 34851510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brugada syndrome ECG provoked by the selective serotonin reuptake inhibitor fluvoxamine.
    Stirnimann G; Petitprez S; Abriel H; Schwick NG
    Europace; 2010 Feb; 12(2):282-3. PubMed ID: 19875396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olanzapine plus fluvoxamine and olanzapine alone for the treatment of an acute exacerbation of schizophrenia.
    Chaichan W
    Psychiatry Clin Neurosci; 2004 Aug; 58(4):364-8. PubMed ID: 15298648
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.
    Apter A; Ratzoni G; King RA; Weizman A; Iancu I; Binder M; Riddle MA
    J Am Acad Child Adolesc Psychiatry; 1994; 33(3):342-8. PubMed ID: 8169178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tolerability and safety of fluvoxamine and other antidepressants.
    Westenberg HG; Sandner C
    Int J Clin Pract; 2006 Apr; 60(4):482-91. PubMed ID: 16620364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SSRI-induced parkinsonism may be an early sign of future Parkinson's disease.
    Gönül AS; Aksu M
    J Clin Psychiatry; 1999 Jun; 60(6):410. PubMed ID: 10401924
    [No Abstract]   [Full Text] [Related]  

  • 47. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group.
    N Engl J Med; 2001 Apr; 344(17):1279-85. PubMed ID: 11323729
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
    Hergüner S; Kilinçaslan A; Görker I; Tüzün U
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):367-9. PubMed ID: 17630870
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluvoxamine for somatoform disorders: an open trial.
    Noyes R; Happel RL; Muller BA; Holt CS; Kathol RG; Sieren LR; Amos JJ
    Gen Hosp Psychiatry; 1998 Nov; 20(6):339-44. PubMed ID: 9854645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial.
    Goodman WK; Kozak MJ; Liebowitz M; White KL
    Int Clin Psychopharmacol; 1996 Mar; 11(1):21-9. PubMed ID: 8732310
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
    Lesaffre E; Molenberghs G; Dewulf L
    Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serotonin syndrome induced by fluvoxamine and oxycodone.
    Karunatilake H; Buckley NA
    Ann Pharmacother; 2006 Jan; 40(1):155-7. PubMed ID: 16368927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatients: a double-blind, multicentre study. The LUCIFER Group.
    Haffmans PM; Timmerman L; Hoogduin CA
    Int Clin Psychopharmacol; 1996 Sep; 11(3):157-64. PubMed ID: 8923094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluvoxamine and clomipramine in depressed hospitalised patients: results from a randomised, double-blind study.
    Ottevanger EA
    Encephale; 1995; 21(4):317-21. PubMed ID: 7588171
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
    Stahl SM
    J Clin Psychiatry; 1998 Dec; 59(12):642-3. PubMed ID: 9921697
    [No Abstract]   [Full Text] [Related]  

  • 58. Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    Menting JE; Honig A; Verhey FR; Hartmans M; Rozendaal N; de Vet HC; van Praag HM
    Int Clin Psychopharmacol; 1996 Sep; 11(3):165-75. PubMed ID: 8923095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluvoxamine dose-dependent interaction with haloperidol and the effects on negative symptoms in schizophrenia.
    Yasui-Furukori N; Kondo T; Mihara K; Inoue Y; Kaneko S
    Psychopharmacology (Berl); 2004 Jan; 171(2):223-7. PubMed ID: 12955290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SSRIs and mammoplasia.
    Marcus P
    Am J Psychiatry; 2001 Jun; 158(6):967. PubMed ID: 11384918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.